Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ViiV Healthcare
With
GlaxoSmithKline
Brief title: drug-drug interaction (DDI)
Primary Purpose: Other : Phase 1 Clinical Pharmacology drug interaction study in healthy subjects
Age
18–50
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy subjects with no clinically significant deviation from normal in medical history, physical examination findings, 12-lead ECG measurements, and clinical laboratory tests
Women of childbearing potential (WOCBP) allowed. Must be practicing highly effective methods of contraception
You may not be if
Any significant acute or chronic medical condition
Unable to tolerate oral medications
Inability to be venipunctured and/or tolerate venous access
Current or recent (within 3 months of dosing) gastrointestinal disease
